Ifebemtinib

Overview

Ifebemtinib (BI 853520) is an orally active and potent focal adhesion kinase ( FAK ) inhibitor (recombinant FAK IC 50 =1 nM). Ifebemtinib shows anti-proliferative activity against cancer cells. Ifebemtinib inhibits FER Kinase and FES Kinase with IC 50 s of 900 nM and 1040 nM, respectively.

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Cancer | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Pancreatic Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > FAK

Product Information

• Catalog No.: HY-122844
• CAS No.: 1227948-82-4
• Molecular Formula: C28H28F4N6O4
• Molecular Weight: 588.55
• Purity: 99.64%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 2.5 mg/mL (4.25 mM); Clear solution
• Availability: In-stock

Source

Original product source